Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $521.98 | 9 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| CVRx, Inc. | $294.12 | 2 | $0 (2024) |
| Boston Scientific Corporation | $104.19 | 1 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $24.78 | 1 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $23.77 | 1 | $0 (2019) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $23.29 | 1 | $0 (2024) |
| KCI USA, Inc. | $18.77 | 1 | $0 (2021) |
| ABBVIE INC. | $18.00 | 1 | $0 (2024) |
| PFIZER INC. | $15.06 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $335.41 | 4 | CVRx, Inc. ($294.12) |
| 2023 | $24.78 | 1 | Janssen Pharmaceuticals, Inc ($24.78) |
| 2021 | $33.83 | 2 | KCI USA, Inc. ($18.77) |
| 2019 | $127.96 | 2 | Boston Scientific Corporation ($104.19) |
All Payment Transactions
9 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/12/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $149.97 | General |
| Category: Heart Failure and Hypertension | ||||||
| 03/20/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $23.29 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 02/01/2024 | ABBVIE INC. | AVYCAZ (Drug), DALVANCE, TEFLARO | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: ANTI-INFECTIVE | ||||||
| 01/25/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $144.15 | General |
| Category: Heart Failure and Hypertension | ||||||
| 09/06/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $24.78 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/30/2021 | PFIZER INC. | ELIQUIS (Drug), VYNDAQEL | Food and Beverage | In-kind items and services | $15.06 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/19/2021 | KCI USA, Inc. | ACTIV.A.C. (Device) | Food and Beverage | Cash or cash equivalent | $18.77 | General |
| Category: Negative Pressure Systems & Dressings | ||||||
| 06/06/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $23.77 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/22/2019 | Boston Scientific Corporation | GENERAL VASCULAR INTERVENTION (Device) | Food and Beverage | In-kind items and services | $104.19 | General |
| Category: VASCULAR | ||||||
About Dr. David Press, MD
Dr. David Press, MD is a Hospitalist healthcare provider based in Lanham, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/03/2007. The National Provider Identifier (NPI) number assigned to this provider is 1851573729.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Press, MD has received a total of $521.98 in payments from pharmaceutical and medical device companies, with $335.41 received in 2024. These payments were reported across 9 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($521.98).
Practice Information
- Specialty Hospitalist
- Other Specialties Hospice and Palliative Medicine
- Location Lanham, MD
- Active Since 12/03/2007
- Last Updated 01/09/2019
- Taxonomy Code 208M00000X
- Entity Type Individual
- NPI Number 1851573729
Products in Payments
- Barostim Neo System (Device) $294.12
- GENERAL VASCULAR INTERVENTION (Device) $104.19
- XARELTO (Drug) $24.78
- ENTRESTO (Drug) $23.77
- LifeVest (Device) $23.29
- ACTIV.A.C. (Device) $18.77
- AVYCAZ (Drug) $18.00
- ELIQUIS (Drug) $15.06
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.